We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-21.98%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
$0
Cap. Flow
-$63.6K
Cap. Flow %
-0%
Top 10 Hldgs %
13.08%
Holding
3,173
New
Increased
3
Reduced
4
Closed

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
26
PepsiCo
PEP
$191B
$160M 0.73%
1,171,110
BIIB icon
27
Biogen
BIIB
$29.5B
$158M 0.72%
533,522
FTNT icon
28
Fortinet
FTNT
$112B
$157M 0.72%
7,358,820
INTC icon
29
Intel
INTC
$462B
$155M 0.7%
2,583,441
PG icon
30
Procter & Gamble
PG
$346B
$146M 0.67%
1,170,805
UNH icon
31
UnitedHealth
UNH
$379B
$144M 0.66%
491,154
VB icon
32
Vanguard Small-Cap ETF
VB
$79.9B
$144M 0.66%
871,629
CVX icon
33
Chevron
CVX
$378B
$138M 0.63%
1,147,791
EA icon
34
Electronic Arts
EA
$52.4B
$138M 0.63%
1,282,715
LRCX icon
35
Lam Research
LRCX
$365B
$134M 0.61%
4,568,770
XOM icon
36
ExxonMobil
XOM
$642B
$134M 0.61%
1,913,198
ROST icon
37
Ross Stores
ROST
$78.1B
$133M 0.61%
1,141,387
PFE icon
38
Pfizer
PFE
$141B
$132M 0.6%
3,554,650
VEA icon
39
Vanguard FTSE Developed Markets ETF
VEA
$227B
$125M 0.57%
2,842,842
AMT icon
40
American Tower
AMT
$77.7B
$121M 0.55%
526,711
APH icon
41
Amphenol
APH
$184B
$119M 0.54%
4,382,332
KEYS icon
42
Keysight
KEYS
$53.6B
$118M 0.54%
1,152,634
CDW icon
43
CDW
CDW
$17.6B
$117M 0.53%
819,316
NKE icon
44
Nike
NKE
$62.5B
$112M 0.51%
1,110,379
ABT icon
45
Abbott
ABT
$182B
$106M 0.48%
1,220,406
CDNS icon
46
Cadence Design Systems
CDNS
$93.4B
$104M 0.47%
1,495,402
PNC icon
47
PNC Financial Services
PNC
$99.6B
$103M 0.47%
642,739
TJX icon
48
TJX Companies
TJX
$173B
$100M 0.46%
1,637,442
MCK icon
49
McKesson
MCK
$99.5B
$99.8M 0.46%
721,758
RTX icon
50
RTX Corp
RTX
$294B
$98M 0.45%
1,039,432

Similar funds

Glenmede Trust's Q1 2020 Portfolio in Review

As of Q1 2020, Glenmede Trust held 3,173 positions worth $21.9B, unchanged from the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 0%. Glenmede Trust opened no new positions and made no exits, leaving the 3,173-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, unchanged from a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust added most to Interpace Biosciences, Inc. Common Stock in Q1 2020, an estimated $51.9K increase.
  • Glenmede Trust's biggest Q1 2020 reduction was Brookfield Infrastructure Partners, cutting an estimated $78.8K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q1 2020.
  • Glenmede Trust opened 0 new positions and closed 0 in Q1 2020.
  • Glenmede Trust's portfolio value was unchanged quarter-over-quarter at $21.9B.

Based on Glenmede Trust's 13F filing for Q1 2020, filed 20 May 2020.